Michal Kantecki
- Infectious Diseases top 5%
- Epidemiology top 10%
- Pharmacology top 10%
- Oncology
- Small Animals top 5%
- Co-authors
- Haran T. SchlammClaudie CharbonneauGregory G. StoneAntonio PagliucaDavid I. MarksRosemary A. BarnesCarlos SolanoSajjad Haider
- Topics
- Antifungal resistance and susceptibility (10 papers)Antimicrobial Resistance in Staphylococcus (9 papers)Fungal Infections and Studies (9 papers)
- Journals
- SHILAP Revista de lepidopterologíaAntimicrobial Agents and ChemotherapyCritical Care
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Michal Kantecki
27 papers receiving 630 citations
Peers
Comparison fields: 5 of 80
- Infectious Diseases 503
- Epidemiology 369
- Pharmacology 121
- Oncology 96
- Small Animals 64
Countries citing papers authored by Michal Kantecki
This map shows the geographic impact of Michal Kantecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Kantecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Kantecki more than expected).
Fields of papers citing papers by Michal Kantecki
This network shows the impact of papers produced by Michal Kantecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Kantecki. The network helps show where Michal Kantecki may publish in the future.
Co-authorship network of co-authors of Michal Kantecki
This figure shows the co-authorship network connecting the top 25 collaborators of Michal Kantecki. A scholar is included among the top collaborators of Michal Kantecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Kantecki. Michal Kantecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System | 3 |
| 8 | 26 | |
| 9 | 3 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 37 | |
| 13 | 3 | |
| 14 | 13 | |
| 15 | 44 | |
| 16 | 14 | |
| 17 | 37 | |
| 18 | 167 | |
| 19 | 49 | |
| 20 | 16 |
About Michal Kantecki
Michal Kantecki is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Molecular Medicine, having authored 28 papers that have together received 645 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Fungal Infections and Studies (9 papers). The work is most often cited by research in Infectious Diseases (503 citations), Applied Microbiology and Biotechnology (46 citations) and Molecular Medicine (53 citations). Michal Kantecki has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Haran T. Schlamm, Claudie Charbonneau, Gregory G. Stone, Antonio Pagliuca, David I. Marks, Rosemary A. Barnes, Carlos Solano, Sajjad Haider, A. Khachatryan and Ľuboš Drgoňa. Their work appears in journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.